3 models fit Virtus Investment Partners Inc. Common Stock and they disagree: 1 of 3 land within 15% of the average. The price is below every model.
Two or more of our models back this value.
Large discount(i)Bronze40
Valued as an asset manager: P/E comparison, Dividend discount, and Residual income.
ACCE opinionVirtus Investment Partners Inc. Common Stock (VRTS)
Fair value (3 models)
$197
ACCE price target
$135
Rating
Undervalued
Horizon
12 months
Fair value published on 19 Oct 2026, 18:04 CEST; previously $190 since 10 Oct 2026, 00:00 CEST.
ACCE price target published on 13 Oct 2026, 00:00 CEST.
Rating published on 19 Oct 2026, 18:04 CEST.
Price used: $119 at the close on 23 Oct 2026, 22:00 CEST.
Models: P/E comparison, Dividend discount, and Residual income.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
Price vs fair value
39.4% below
+65.0% to fair value
ACCE score
43
out of 100
Analysts
25% buy
4 covering
P/E
6.8x
forward 7.7x
1-year return
-32.8%
Dividend yield
8.04%
Virtus Investment Partners Inc. Common Stock in four questions
Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
Overview
ACCE thesis
Virtus Investment Partners runs a multi-boutique asset management platform, with the bulk of its assets in active fixed income and equity strategies run by affiliated sub-advisers such as Kayne Anderson Rudnick and Ceredex, alongside ETF and alternatives products. Its edge is in the boutiques' niche capabilities, but revenue has been shrinking at 4.4%, which is the core problem the company has to solve. Near-term sentiment will hinge on whether flows stabilise and whether the cost base can keep margins near an 11.8% operating level as assets under management stay under pressure. The stock trades at 7.0 times trailing earnings and 7.7 times forward, with a 10.7% return on equity, so the price already reflects a lot of skepticism about the top line. The investment case rests on a turnaround in net flows, which the current data does not yet show, and the score of 45 out of 100 says the screen agrees.
⚠ Investor warnings · 4 flagsAI-assisted·How I use AI
high
Negative free cash flow
Free cash flow was -$74.1M while debt-to-equity sits at 3.04. The company is consuming cash and leaning on a heavy debt load to do it.
moderate
Revenue shrinking year over year
Revenue fell 4.4% year over year, even though five-year revenue CAGR is 6.6%. Top-line momentum has turned negative in the latest period.
moderate
Elevated short interest
Short interest stands at 11.3% of float. That signals meaningful bearish positioning against the stock.
moderate
Weak ACCE score
The ACCE score is 44/100, with growth at 27 and momentum at 17. The stock trades 11.6% below the ACCE price target of $135.00, which gives little margin of safety on the score alone.
AI research notes
AI-assisted·How I use AIWritten Oct 19, 2026 · figures from 2026-10-14 · prices to Oct 23, 2026
Why it could do well
The stock trades at a trailing P/E of 7.0x, well below the sector median forward P/E of 11.9x.
The consensus model fair value of $196.86 sits 39.4% above the current price of $119.31, according to three valuation models.
The dividend yield is 7.8%, and the share count fell 3.9% in the last fiscal year, supporting per-share returns.
Why it could disappoint
Free cash flow over the last twelve months was negative at -$74M, so the business is not generating cash after spending.
Revenue fell 4.4% year over year, and the latest earnings per share missed expectations by 9.0%.
Debt to equity of 3.04 leaves the balance sheet heavily leveraged, and return on invested capital is only 3.0%.
Each chip shows the exact figure and where it comes from. A claim without a source is not published.
Next results
Oct 30, 2026
We update the fair value about 2 days after the results, once the new figures are filed.Add to calendarGoogle
Walk me through this stock
Plain-English pros, cons, and what to watch. Pro feature.
PRO
Ask ACCE
Valuation
INVESTOR
Where VRTS's valuation models land
Price
$119.31
Model fair value
$197
Model range
$127 to $269
Fair value $197
Price $119
The price is below the whole model range.
Model
Fair value
Upside
Dividend discount
P/E comparison
Residual income
Create a free account: 5 full stock pages a month, no card.
See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.
Quality
INVESTOR
Quality and conviction INVESTOR FEATURE
The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.
+A plain reason under every score
+Conviction breakdown and growth / value / quality / momentum scores